ரோச்சர் மார்க் டெலாநே News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ரோச்சர் மார்க் டெலாநே. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ரோச்சர் மார்க் டெலாநே Today - Breaking & Trending Today

Valbiotis Announces the Publication of the First Scientific Papers on TOTUM•63 in Three International Journals, Elucidating Its Multitarget Mode of Action

The scientific papers, presenting preclinical and clinical Phase I/II results for TOTUM•63, have been accepted and published in three international peer-reviewed journals: the American Journal of ....

United States , South Africa , Clermont Auvergne , Carole Rocher Marc Delaunay , Claude Bernard University In Lyon , American Physiology Society , Research Development , Leiden University Netherlands , Nutrition Health , European Union , Innovative Company , Rochelle University , European Regional Development Fund , Health Science , Young Innovative Company , University Of Clermont Auvergne , International Journal Of Obesity , Vanderbilt University In Nashville United States , Clermont Auvergne Clinical Investigation Center Centre , American Journal , International Journal , Chief Scientific Officer , Valbiotis Board , Impact Factor , Clermont Auvergne Clinical Investigation Center , Claude Bernard University ,

Valbiotis' Combined General Meeting on May 27, 2021 Will Exceptionally Be Held Behind Closed Doors

Shareholders are invited to vote remotely Regulatory News: Valbiotis (Paris:ALVAL) (FR0013254851 ALVAL, PEA SME eligible), a Research and Development company committed to scientific innovation ....

France General , Carole Rocher Marc Delaunay , European Regional Development Fund , Young Innovative Company , European Union , Research Development , Innovative Company , Board Of Directors The Company , Paribas Securities Services , Combined General Meeting , French Government Ordinance , French Commercial Code , Securities Services , Grands Moulins , General Meeting , French Financial Markets Regulator , Communication Valbiotis , Rocher Marc Delaunay , Communication Actifin , பிரான்ஸ் ஜநரல் , கரோல் ரோச்சர் மார்க் டெலாநே , ஐரோப்பிய பிராந்திய வளர்ச்சி நிதி , இளம் புதுமையானது நிறுவனம் , ஐரோப்பிய தொழிற்சங்கம் , ஆராய்ச்சி வளர்ச்சி , புதுமையானது நிறுவனம் ,

VALBIOTIS Releases Its 2020 Annual Results

VALBIOTIS Releases Its 2020 Annual Results
2020 highlights and results
Global strategic partnership with Nestlé Health Science for the development and marketing of TOTUM-63, a plant-based active substance with clinically proven metabolic health benefits in prediabetic subjects.
Launch of REVERSE-IT, a global pivotal Phase II/III clinical trial of TOTUM-63 for reducing Type 2 Diabetes risk factors.
New milestones achieved with TOTUM-070, a plant-based active substance for lowering LDL-cholesterol, a risk factor for cardiovascular disease.
€14.6m in cash as at December 31, 2020.
Post-balance sheet events and outlook
Important milestones are expected to be reached in the development of TOTUM-070 (reduction in blood LDL-cholesterol levels). ....

United States , Carole Rocher Marc Delaunay , European Association For The Study Of Diabetes , European Regional Development Fund , Health Products Safety , American Heart Association , European Society Of Hypertension , Health Science , French National Agency For Medicines , International Society Of Hypertension , American Diabetes Association , Research Development , Young Innovative Company , Research Tax Credit , European Union , Innovative Company , French Ethics Committee , Regulatory News , First Patient Visit , French National Agency , European Association , Management Board , Statutory Auditor , European Society , International Society , French Financial Markets Regulator ,

VALBIOTIS: 2021 Financial Communication Calendar

VALBIOTIS: 2021 Financial Communication Calendar
Regulatory News:
VALBIOTIS (Paris:ALVAL) (FR0013254851 ALVAL eligible for the PEA/SME), a Research Development company committed to scientific innovation for preventing and combating metabolic diseases, today presents its 2021 financial communication calendar.
March, 17: Annual Report (after market closing)
May, 27: General Meeting (terms of participation to be specified later)
September, 30: Half-year Report (after market closing)
ABOUT VALBIOTIS
VALBIOTIS is a Research Development company committed to scientific innovation for preventing and combating metabolic diseases in response to unmet medical needs.
VALBIOTIS has adopted an innovative approach, aiming to revolutionize healthcare by developing a new class of nutritional health solutions designed to reduce the risk of major metabolic diseases, based on a multi-target approach and made possible by the use of plant-based ingredients. ....

France General , Carole Rocher Marc Delaunay , European Regional Development Fund , Young Innovative Company , European Union , Research Development , Innovative Company , Regulatory News , Annual Report , General Meeting , Half Year Report , French Financial Markets Regulator , Rocher Marc Delaunay , பிரான்ஸ் ஜநரல் , கரோல் ரோச்சர் மார்க் டெலாநே , ஐரோப்பிய பிராந்திய வளர்ச்சி நிதி , இளம் புதுமையானது நிறுவனம் , ஐரோப்பிய தொழிற்சங்கம் , ஆராய்ச்சி வளர்ச்சி , புதுமையானது நிறுவனம் , ஒழுங்குமுறை செய்தி , ஆண்டு அறிக்கை , ஜநரல் சந்தித்தல் , பாதி ஆண்டு அறிக்கை , பிரஞ்சு நிதி சந்தைகள் சீராக்கி , ரோச்சர் மார்க் டெலாநே ,